Skip to main content
Skip to "About this site"

Table A.54.1

Warning View the most recent version.

Archived Content

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please "contact us" to request a format other than those available.

Table A.54.1
Reasons for attempting to raise capital in 2014 and/or 2015, by region, 2014 and 2015
Table summary
This table displays the results of Reasons for attempting to raise capital in 2014 and/or 2015. The information is grouped by Region (appearing as row headers), Establishments seeking financing, calculated using number units of measure (appearing as column headers).
Region	Establishments seeking financing
Region	number
Canada
R&D or expand R&D capacity	69^{Table A.54.1 Note C}
Proof of concept or pilot project	51^{Table A.54.1 Note C}
Acquire new plant or facility	28^{Table A.54.1 Note D}
Expanding current facility	31^{Table A.54.1 Note D}
Retrofit of existing facility	17^{Note E: Use with caution}
Market or commercialize bioproducts	35^{Table A.54.1 Note D}
Operating funds	39^{Table A.54.1 Note D}
Repay current investors	9^{Note E: Use with caution}
Other reasons	8^{Note E: Use with caution}
Atlantic provinces
R&D or expand R&D capacity	8^{Note E: Use with caution}
Proof of concept or pilot project	8^{Note E: Use with caution}
Acquire new plant or facility	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Expanding current facility	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Retrofit of existing facility	0
Market or commercialize bioproducts	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Operating funds	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Repay current investors	0
Other reasons	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Quebec
R&D or expand R&D capacity	21^{Table A.54.1 Note D}
Proof of concept or pilot project	14^{Table A.54.1 Note D}
Acquire new plant or facility	8^{Note E: Use with caution}
Expanding current facility	11^{Note E: Use with caution}
Retrofit of existing facility	10^{Note E: Use with caution}
Market or commercialize bioproducts	10^{Note E: Use with caution}
Operating funds	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Repay current investors	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Other reasons	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Ontario
R&D or expand R&D capacity	20^{Table A.54.1 Note D}
Proof of concept or pilot project	12^{Note E: Use with caution}
Acquire new plant or facility	7^{Note E: Use with caution}
Expanding current facility	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Retrofit of existing facility	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Market or commercialize bioproducts	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Operating funds	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Repay current investors	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Other reasons	0
Prairies
R&D or expand R&D capacity	11^{Note E: Use with caution}
Proof of concept or pilot project	11^{Note E: Use with caution}
Acquire new plant or facility	6^{Note E: Use with caution}
Expanding current facility	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Retrofit of existing facility	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Market or commercialize bioproducts	9^{Note E: Use with caution}
Operating funds	11^{Note E: Use with caution}
Repay current investors	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Other reasons	0
British Columbia
R&D or expand R&D capacity	10^{Note E: Use with caution}
Proof of concept or pilot project	6^{Note E: Use with caution}
Acquire new plant or facility	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Expanding current facility	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Retrofit of existing facility	0
Market or commercialize bioproducts	6^{Note E: Use with caution}
Operating funds	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Repay current investors	0
Other reasons	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
x suppressed to meet the confidentiality requirements of the Statistics Act ^E use with caution Note: Coefficient of variation (CV) threshold Note C [ 0.100 < CV ≤ 0.150 ] Return to note C referrer Note D [ 0.150 < CV ≤ 0.250 ] Return to note D referrer Preliminary estimates, subject to change. Due to rounding, components may not add to totals. Coefficient of variation (CV) and standard error (SE) are used as quality indicators. Source: Statistics Canada, Bioproducts production and development survey 2015.

Date modified:: 2017-12-22